The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Global Genomic Response to Neonatal Screening
Abstract
In the age of genomic science, neonatal screening for sickle cell anemia involves critical ethical legal, social, and financial implications. The screening for early identification of children most likely to face the complications associated with sickle cell disease was designed to enable parents utilize the state of the art scientific curative care to enable their children to live economically productive lifestyle. However, screening must not be used for discrimination and refusal to insure patient with sickle cell disease. The availability of bone marrow transplant and gene-therapies are clinical options to assist at-risk patients.
Related Content
Kedmon Nyasha Hungwe, Ashley R. Rakatsinzwa, Felix Mukono.
© 2024.
15 pages.
|
Josephine Atieno Otiende.
© 2024.
16 pages.
|
Babatunde Adeyeye, Abiodun Salawu.
© 2024.
15 pages.
|
Wendo Nabea.
© 2024.
13 pages.
|
Billy James, Wilfred W. Wilfred.
© 2024.
16 pages.
|
Manisha Nitin Gore, Reshma Patil, Revati Pathak.
© 2024.
16 pages.
|
Kgomotso Theledi, Violet M. S Pule.
© 2024.
16 pages.
|
|
|